U.K. scrutinizes antipsychotic use

Add to a host of U.S. probes a new U.K. look at the use of antipsychotic drugs in dementia patients. British ministers have ordered a review of the meds, which have been linked to an increased risk of death in elderly patients with dementia, but continue to be used to pacify aggressive and disturbed patients. It's part of a new effort in the U.K. to codify dementia treatment, in anticipation of a huge increase in cases as the population ages.

- read the BBC report
- check out the story in The Guardian

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.